Starch microparticles as vaccine adjuvant

@article{Rydell2005StarchMA,
  title={Starch microparticles as vaccine adjuvant},
  author={Niclas Rydell and Linda Stertman and Ingvar Sjöholm},
  journal={Expert Opinion on Drug Delivery},
  year={2005},
  volume={2},
  pages={807 - 828},
  url={https://api.semanticscholar.org/CorpusID:23506603}
}
This review gives an account of the different starch adjuvants used in immunisation studies and the properties of polyacryl starch microparticles as an oral vaccine adjuvant that induce protective immune responses in mice challenge experiments are summarized.
View on Taylor & Francis
ncbi.nlm.nih.gov
31 Citations
Background Citations
8
Methods Citations
1

31 Citations

Use of an oral diphtheria vaccine in human.

Raw starch microparticles have immunostimulant activity in mice vaccinated with BCG and challenged with Mycobacterium tuberculosis.

Bioadhesive delivery systems for mucosal vaccine delivery

It appears most likely that successful mucosal vaccination will require the addition of vaccine adjuvants for optimal immune responses, particularly if they are to be used in an unprimed population.

Starch microparticles as a vaccine adjuvant: only uptake in Peyer's patches decides the profile of the immune response.

Non-ionic surfactant technology for the delivery and administration of sub-unit flu antigens

This thesis demonstrates that niosomes can be used as delivery systems for peptides and protein sub-unit antigens by providing antigen protection thereby, enhancing vaccine efficacy when administered orally and intramuscularly.

Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation

Vaccines , Adjuvants , and Delivery Systems for Infectious Diseases

The best approach for reducing the death and suffering of humans and animals due to viral, bacterial, and parasitic diseases is prevention using effective vaccines, and the technology of vaccine development and production has not changedSignificantly over the years.

Formulation design considerations for oral vaccines.

The options available for consideration when building effective oral particulate vaccines are established and it is established that formulating particulates with inherent adjuvant properties can offer advantages.

Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases

This review elucidates the potential and current status of intranasal delivery systems, while also serving as a reference point for the future development of intranasal vaccines.

In vivo tracing of immunostimulatory raw starch microparticles after mucosal administration.

167 References

Polyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in mice.

Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice.

Chitosan for mucosal vaccination.

Starch Microparticles as Oral Vaccine Adjuvant: Antigen-dependent Uptake in Mouse Intestinal Mucosa

The qualitative difference in uptake could be of importance for the development of an immune response as the cytokine and chemokine microenvironment during antigen presentation will decide the differentiation of the immune response induced.

Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant.

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.

Immunity in response to particulate antigen-delivery systems.

Mucosal vaccination against diphtheria using starch microparticles as adjuvant for cross-reacting material (CRM197) of diphtheria toxin.

Extracellular Antigens from Salmonella enteritidis Induce Effective Immune Response in Mice after Oral Vaccination

The delayed-type hypersensitivity test, as a measure of the cellular response, showed a significant increase in ear thickness in all the immunized groups, except for the group that received free antigen orally, compared to the nonimmunized group.

Oral administration of polymer-grafted starch microparticles activates gut-associated lymphocytes and primes mice for a subsequent systemic antigen challenge.

...